The American Cancer Society has reported that US Cancer Death Rates have fallen between 1% and 2% each year since 1991. That is an overall decease of 27% since 1991.
Click on his link to visit the Wiley Online Library to read the Cancer Journal for Clinicians and the published report titled: “Cancer statistics, 2019“.
You can download a PDF of that American Cancer Society report at the link above.
I suspect that the trend will continue as Medical Cannabis becomes legal in more States. Why? It has been shown that THC Oil (made from Cannabis) can be an effective treatment protocol for some individuals and some Cancers. THC has been shown to kill cancer cells in lab studies. Human cases (not peer reviewed studies) have had THC inhibit the growth and metastasis of Lung Cancer for Example. THC Oil is credited with shrinking inoperable Brain Tumors is another example. As Cannabis becomes legal there, will be new Medical Studies done on it.
There is also another report which states that smoking in the US is at a record low. Fewer people smoking will result in fewer people getting Lung Cancer or Heart Disease and other complications due to smoking cigarettes. In the near future I will do a post on that report.
Back in 2007, the American Association for Cancer Research published Information about research which was presented at their annual meeting by
BIDMC, Harvard University, Boston, MA
The closing important paragraph from the Abstract published by the Cancer Research Journal is below:
Cumulatively, these studies indicate that THC has anti-tumorigenic and anti-metastatic effects against lung cancer. Novel therapies against EGFR overexpressing, aggressive and chemotherapy resistant lung cancers may include targeting the cannabinoids receptors.
Posted by: Vincent Banial
Harvard University brought together researchers studying Marijuana’s health impacts with policymakers who are working to implement new laws in ways that will benefit and protect public health.
Video courtesy of the Harvard University YouTube channel
Click on this link to visit the National Cancer Institute website.
The following is from the National Cancer Institute webpage linked to above titled “Cannabis and Cannabinoids (PDQ®)–Patient Version
Questions and Answers About Cannabis”
Have any preclinical (laboratory or animal) studies been conducted using Cannabis or cannabinoids?
Preclinical studies of cannabinoids have investigated the following:
Studies in mice and rats have shown that cannabinoids may inhibit tumor growth by causing cell death, blocking cell growth, and blocking the development of blood vessels needed by tumors to grow. Laboratory and animal studies have shown that cannabinoids may be able to kill cancer cells while protecting normal cells.
A laboratory study of cannabidiol (CBD) in estrogen receptor positive and estrogen receptor negative breast cancer cells showed that it caused cancer cell death while having little effect on normal breast cells. Studies in mouse models of metastatic breast cancer showed that cannabinoids may lessen the growth, number, and spread of tumors.
A review of 34 studies of cannabinoids in glioma tumor models found that all but one study showed that cannabinoids can kill cancer cells without harming normal cells.
A laboratory study of cannabidiol (CBD) in human glioma cells showed that when given along with chemotherapy, CBD may make chemotherapy more effective and increase cancer cell death without harming normal cells. Studies in mouse models of cancer showed that CBD together with delta-9-THC may make chemotherapy such as temozolomide more effective.
Posted by: Vincent Banial